3. Multivariate analyses of baseline parameters

3.2 Significance of variables

  • Max Nodal Size
  • Number of Prior therapies
  • IGHV unmutated
  • TP53 mutation number

3.2.1 TP53 and/or 17pDEL (Both)

<U+6211> 0 0 0 0 0 0 0
<U+6211> 0 0 0 0 0 0 0